✦ LIBER ✦

Decreasing smoking behaviour and risk through CYP2A6 inhibition

✍ Scribed by Edward M. Sellers; Rachel F. Tyndale; Leona C. Fernandes

Book ID: 114384372
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 57 KB
Volume: 8
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(03)02704-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP2A6 inhibition beneficial in smoking?

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

CYP2A6 genotype and smoking

✍ Tiihonen, J; Pesonen, U; Kauhanen, J; Koulu, M; Hallikainen, T; Leskinen, L; Sal 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Genetic variation of CYP2A6, smoking, an

Genetic variation of CYP2A6, smoking, and risk of cancer

✍ Stephanie J London; Jeffrey R Idle; Ann K Daly; Gerhard A Coetzee 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 66 KB

585 The role of CYP2A6 polymorphism in s

585 The role of CYP2A6 polymorphism in smoking behaviour and nicotine dependence

✍ Stefania Morandi; Alfredo Nunziata; Cristina Andreoli 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Forecasting CYP2D6 and CYP3A4 Risk with

Forecasting CYP2D6 and CYP3A4 Risk with a Global/Local Fusion Model of CYP450 Inhibition

✍ Todd Ewing; Miklos Feher 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 748 KB

## Abstract This work presents a method to utilize the ever‐expanding corporate collections of CYP450 inhibition data to forecast the future risk of compounds not yet synthesized. The global/local fusion method differs from existing QSAR methods, in that each prediction is derived from a custom‐bui

Combined analysis of CHRNA5, CHRNA3 and

Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour

✍ Rodriguez, S.; Cook, D. G.; Gaunt, T. R.; Nightingale, C. M.; Whincup, P. H.; Da 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 155 KB